A Centrally Acting Antihypertensive, Clonidine, Sedates Patients Presenting With Acute Respiratory Distress Syndrome Evoked by Severe Acute Respiratory Syndrome-Coronavirus 2
- 29 June 2020
- journal article
- letter
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 48 (10) , e991-e993
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 19 references indexed in Scilit:
- Failure of Noninvasive Ventilation for De Novo Acute Hypoxemic Respiratory FailureCritical Care Medicine, 2016
- Swift recovery of severe hypoxemic pneumonia upon morbid obesity.2014
- Spontaneous ventilation-high PEEP upon severe ARDS: An erratum to further the analysisMedical Hypotheses, 2013
- Prone Positioning in Severe Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2013
- Effect of different seated positions on lung volume and oxygenation in acute respiratory distress syndromeIntensive Care Medicine, 2013
- Dexmedetomidine and clonidine induce long-lasting activation of the respiratory rhythm generator of neonatal mice: Possible implication for critical careRespiratory Physiology & Neurobiology, 2012
- Neuromuscular Blockers in Early Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2010
- Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilationIntensive Care Medicine, 2008
- Clinical pharmacology and pharmacokinetics of clonidineClinical Pharmacology & Therapeutics, 1976
- Clonidine: A new antihypertensive agentThe American Journal of Cardiology, 1971